EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer

Renju Pun, Niti Kumari, Rodaina Hazem Monieb, Sachin Wagh, Brian J North

Seminars in Cancer Biology · 2024

DOI: 10.1016/j.semcancer.2024.10.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024. Verfasst von Renju Pun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences Department, Creighton University School of Medicine, Omaha, NE, USA. Hauptthemen laut MEDLINE: Neoplasms, Sirtuin 2, Aging, Aneuploidy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, U.S. Department of Health and Human Services, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is a significant risk factor for cancer which is due, in part, to heightened genomic instability. Mitotic surveillance proteins such as BubR1 play a pivotal role in ensuring accurate chromosomal segregation and preventing aneuploidy. BubR1 levels have been shown to naturally decline with age and its loss is associated with various age-related pathologies. Sirtuins, a class of NAD+-dependent deacylases, are implicated in cancer and genomic instability. Among them, SIRT2 acts as an upstream regulator of BubR1, offering a critical pathway that can potentially mitigate age-related diseases, including cancer. In this review, we explore BubR1 as a key regulator of cellular processes crucial for aging-related phenotypes. We delve into the intricate mechanisms through which BubR1 influences genomic stability and cellular senescence. Moreover, we highlight the role of NAD+ and SIRT2 in modulating BubR1 expression and function, emphasizing its potential as a therapeutic target. The interaction between BubR1 and SIRT2 not only serves as a fundamental regulatory pathway in cellular homeostasis but also represents a promising avenue for developing targeted therapies against age-related diseases, particularly cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSirtuin 2AgingAneuploidyProtein Serine-Threonine KinasesHumansAnimalsCellular SenescenceGenomic Instability

Stichwörter der Autor:innen

AgingAneuploidyBubR1CancerSIRT2SenescenceSirtuins

Substanzen

Sirtuin 2Protein Serine-Threonine KinasesBUB1 protein, humanSIRT2 protein, human

Autor:innen und Institutionen

  • Biomedical Sciences Department, Creighton University School of Medicine, Omaha, NE, USA.
  • Biomedical Sciences Department, Creighton University School of Medicine, Omaha, NE, USA. Electronic address: BrianNorth@creighton.edu.

Förderung

  • NIA NIH HHS
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • Nebraska Department of Health and Human Services
  • Creighton University
  • National Institute on Aging

Zitieren

APA

Pun, R., Kumari, N., Monieb, R. H., Wagh, S., & North, B. J. (2024). BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2024.10.005

Vancouver

Pun R, Kumari N, Monieb RH, Wagh S, North BJ. BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer. Seminars in Cancer Biology. 2024. doi:10.1016/j.semcancer.2024.10.005

BibTeX
@article{Pun2024,
  author = {Pun, Renju and Kumari, Niti and Monieb, Rodaina Hazem and Wagh, Sachin and North, Brian J},
  title = {BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer},
  journal = {Seminars in Cancer Biology},
  year = {2024},
  doi = {10.1016/j.semcancer.2024.10.005}
}
Kostenlos starten →